ÜLKER BİSKÜVİ SANAYİ A.Ş.

Capital/Financing Update • Jul 2, 2024

Summary Info	Recent developments on the issuance of debt securities abroad
Update Notification Flag	Yes
Correction Notification Flag	No
Postponed Notification Flag	No

Authorized Member Decision Date	12.03.2024
Issue Limit	550.000.000
Currency Unit	USD
Issue Limit Security Type	Debt Securities
Sale Type	Oversea
Domestic / Oversea	Oversea
Capital Market Board Application Date	12.03.2024
Capital Market Board Application Result	APPROVAL
Capital Market Board Approval Date	09.05.2024
Expiry Date of Issue Limit	09.05.2025

Additional Explanations

The book building process for the sale of our Company's bonds to qualified investors outside Türkiye in accordance with "Rule 144A" and "Regulation S," and to be listed on the Irish Stock Exchange, has been successfully completed. Starting from June 27, 2024 for a period of 2 business days, the senior management of our Company met with potential investors residing outside of Türkiye. With the participation of more than 100 investors from 20 countries, the bond issue received an order of USDbn 1.4 whereas the initial offering target was USD 550 million. As a result, our Company resolved to proceed with the issuance with a nominal amount of USD 550 million and a maturity of 7 years with an annual yield of %7.875. The transaction process is expected to be completed on July 8, 2024 following the signing of the subscription agreement and obtaining approval for the tranche issuance certificate from the Capital Markets Board. Upon the completion of the issuance, the totality of the insurance limit approved by the Capital Markets Board on May 9, 2024 will have been used. Any further developments will be disclosed to the public.